Skip to main content

Cragg David's Form 4 filing

Cytokinetics Inc (CYTK) · filed Nov 9, 2021

Accession no.
0001061983-21-000255
Filed
Nov 9, 2021
Trade date
Nov 9, 2021
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.88M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cragg DavidCIK 0001316459Officer (Chief HR & Admin Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 9, 2021Common StockMOption exerciseAcquired+24,519$9.65+$236,608.35163,223Direct
Nov 9, 2021Common StockSSaleDisposed−24,519$41.76−$1,023,913.44138,704Direct
Nov 9, 2021Common StockMOption exerciseAcquired+20,481$9.65+$197,641.65159,185Direct
Nov 9, 2021Common StockSSaleDisposed−20,481$41.76−$855,286.56138,704Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 9, 2021Common StockMOption exerciseDisposed−20,481$0.00$00Direct
Nov 9, 2021Common StockMOption exerciseDisposed−24,519$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)